bifendate has been researched along with Fatty Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, H; Ko, KM; Pan, SY; Yang, R; Yu, ZL | 1 |
| Akbar, N; Liu, G; Noer, HM; Santoso, WD; Tahir, RA | 1 |
1 trial(s) available for bifendate and Fatty Liver
| Article | Year |
|---|---|
Effectiveness of the analogue of natural Schisandrin C (HpPro) in treatment of liver diseases: an experience in Indonesian patients.
Topics: Adolescent; Adult; Aged; Dioxoles; Double-Blind Method; Drugs, Chinese Herbal; Fatty Liver; Female; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Male; Middle Aged; Prospective Studies | 1998 |
1 other study(ies) available for bifendate and Fatty Liver
| Article | Year |
|---|---|
Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice.
Topics: Animals; Bile Acids and Salts; Biphenyl Compounds; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Dose-Response Relationship, Drug; Fatty Liver; Fenofibrate; Hypercholesterolemia; Hypolipidemic Agents; Male; Mice; Mice, Inbred ICR; Time Factors; Triglycerides | 2006 |